eHealth earnings are due November 4, 2026: eHealth stock loses 87.20 percent YTD

Published on 10/17/2026 at 20:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue was USD 33.57 million in the second quarter of 2026. eHealth stock closed at USD 0.59 on October 16, 2026, down 3.28 percent versus the prior close.

Scheduled earnings and valuation

eHealth is estimated to report third-quarter results on November 4, 2026.
Second-quarter revenue reached USD 33.57 million for the period ended June 30, 2026.
eHealth stock costs USD 0.59 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 3.28 percent versus the prior close.
MarketBeat lists a USD 2.19 average target based on six analysts.

EHTH, US28238P1093, Illustration mit AI erstellt.

eHealth is estimated to report third-quarter 2026 results on November 4, 2026, before the Nasdaq open, with consensus revenue of USD 27.10 million, according to MarketBeat. On Nasdaq, eHealth stock stood at USD 0.59 on October 16, 2026 at 4:00 p.m. ET, down 3.28 percent versus the prior close.

Revenue fell to USD 33.57 million

For the second quarter ended June 30, 2026, revenue was USD 33.57 million and the net loss attributable to common shareholders was USD 37.51 million. Diluted earnings per share were negative USD 1.18. The revenue figure was close to the USD 33.28 million estimate cited by MarketBeat, while the loss per share missed its USD 0.84 consensus estimate.

Range leaves little room

The Nasdaq session ranged from USD 0.57 to USD 0.62 on October 16, 2026. The 52-week range was USD 0.57 to USD 5.89, putting the closing price 89.98 percent below the high and 3.51 percent above the low. Volume reached 230,819 shares against an average of 307,762.

The October 14, 2026 Nasdaq notice remains a relevant listing factor. In its Form 8-K, the SEC filing said the stock had closed below the USD 1.00 minimum bid requirement for 30 consecutive business days. The company received until April 12, 2027 to regain compliance.

Target remains above the quote

MarketBeat lists a USD 2.19 average target based on six analysts and a Reduce consensus. The target stands 271.19 percent above the USD 0.59 Nasdaq price, while the finance data shows a negative P/E of -0.65 and market capitalization of USD 18.6 million.

Comparison with peers on October 16, 2026

EHTH (Nasdaq, USD): minus 3.28 percent, P/E -0.65, market capitalization USD 18.6 million

Humana (NYSE, USD): minus 4.37 percent, P/E 39.14, market capitalization USD 49.6 billion

Centene (NYSE, USD): minus 1.91 percent, P/E -6.62, market capitalization USD 34.2 billion

What comes next

The next scheduled company date is November 4, 2026, when eHealth is estimated to publish third-quarter results before the market opens. Revenue expectations of USD 27.10 million would represent a further USD 6.47 million decline from the second quarter.

Stock closes near its yearly low

The Nasdaq closing price of October 16, 2026 was USD 0.59, down 3.28 percent from the prior close. The narrow distance to the 52-week low contrasts with the USD 2.19 average analyst target.